Form 8-K - Current report:
SEC Accession No. 0001999371-24-001277
Filing Date
2024-01-31
Accepted
2024-01-31 17:17:31
Documents
14
Period of Report
2024-01-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk-8k_012524.htm   iXBRL 8-K 34670
  Complete submission text file 0001999371-24-001277.txt   207592

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE dmk-20240125.xsd EX-101.SCH 2985
3 XBRL LABEL FILE dmk-20240125_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE dmk-20240125_pre.xml EX-101.PRE 22340
15 EXTRACTED XBRL INSTANCE DOCUMENT dmk-8k_012524_htm.xml XML 3595
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 24583952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)